Victory Capital Management
ELAN icon

Victory Capital Management’s Elanco Animal Health ELAN Stock Holding History

Victory Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.12M Buy
289,260
+10,945
+4% +$253K ﹤0.01% 1257
2026
Q1 		$6.66M Buy
278,315
+51,324
+23% +$1.25M ﹤0.01% 1222
2025
Q4 		$5.14M Buy
226,991
+8,948
+4% +$195K ﹤0.01% 1306
2025
Q3 		$4.39M Sell
218,043
-9,087
-4% -$152K ﹤0.01% 1379
2025
Q2 		$3.24M Sell
227,130
-44,208
-16% -$517K ﹤0.01% 1455
2025
Q1 		$2.85M Buy
271,338
+157,708
+139% +$1.78M ﹤0.01% 1445
2024
Q4 		$1.38M Buy
113,630
+11,216
+11% +$147K ﹤0.01% 1647
2024
Q3 		$1.5M Buy
102,414
+9,480
+10% +$132K ﹤0.01% 1594
2024
Q2 		$1.34M Sell
92,934
-5,219
-5% -$83.4K ﹤0.01% 1578
2024
Q1 		$1.6M Buy
98,153
+32,641
+50% +$510K ﹤0.01% 1526
2023
Q4 		$976K Buy
65,512
+11,910
+22% +$135K ﹤0.01% 1733
2023
Q3 		$602K Sell
53,602
-201
-0.4% -$2.33K ﹤0.01% 1903
2023
Q2 		$541K Sell
53,803
-1,257
-2% -$11.7K ﹤0.01% 1946
2023
Q1 		$518K Sell
55,060
-223,734
-80% -$2.64M ﹤0.01% 1989
2022
Q4 		$3.41M Buy
278,794
+33,635
+14% +$419K ﹤0.01% 1293
2022
Q3 		$3.04M Buy
245,159
+31,324
+15% +$548K ﹤0.01% 1355
2022
Q2 		$4.2M Buy
213,835
+39,129
+22% +$926K ﹤0.01% 1284
2022
Q1 		$4.52M Sell
174,706
-71,844
-29% -$1.91M ﹤0.01% 1315
2021
Q4 		$7M Sell
246,550
-2,226
-0.9% -$69.2K 0.01% 1234
2021
Q3 		$7.93M Sell
248,776
-6,760
-3% -$227K 0.01% 1166
2021
Q2 		$8.86M Buy
255,536
+4,349
+2% +$143K 0.01% 1161
2021
Q1 		$7.4M Buy
251,187
+108,721
+76% +$3.34M 0.01% 1219
2020
Q4 		$4.37M Sell
142,466
-40,752
-22% -$1.24M ﹤0.01% 1274
2020
Q3 		$5.12M Buy
183,218
+27,582
+18% +$699K 0.01% 1198
2020
Q2 		$3.34M Sell
155,636
-82,605
-35% -$1.82M ﹤0.01% 1272
2020
Q1 		$5.33M Sell
238,241
-29,532
-11% -$809K 0.01% 1066
2019
Q4 		$7.89M Buy
267,773
+13,090
+5% +$356K 0.01% 1076
2019
Q3 		$6.77M Buy
+254,683
New +$7.64M 0.01% 1095

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Victory Capital Management's ELAN Position: Q2 2026 in Review

Victory Capital Management increased its Elanco Animal Health (ELAN) stake by 3.9% in Q2 2026, buying an estimated $253K and bringing the position to 289,260 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Victory Capital Management first reported a position in ELAN in Q3 2019 and has held it in 28 quarters since. The position peaked at $8.86M in Q2 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Victory Capital Management held 289,260 shares of Elanco Animal Health worth $7.12M as of Q2 2026.
  • Victory Capital Management bought 10,945 Elanco Animal Health shares in Q2 2026, an estimated $253K.
  • Elanco Animal Health made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1257 holding.
  • Victory Capital Management first reported a position in Elanco Animal Health in Q3 2019 and has held it in 28 quarters since.
  • Victory Capital Management's Elanco Animal Health position peaked at $8.86M in Q2 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.